These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. 20S Proteasome as a Drug Target in Trichomonas vaginalis. O'Donoghue AJ; Bibo-Verdugo B; Miyamoto Y; Wang SC; Yang JZ; Zuill DE; Matsuka S; Jiang Z; Almaliti J; Caffrey CR; Gerwick WH; Eckmann L Antimicrob Agents Chemother; 2019 Nov; 63(11):. PubMed ID: 31451503 [TBL] [Abstract][Full Text] [Related]
4. The antimicrobial peptides LL-37, KR-20, FK-13 and KR-12 inhibit the growth of a sensitive and a metronidazole-resistant strain of Trichomonas vaginalis. Ramírez-Ledesma MG; Rodríguez MC; Alva-Murillo N; Avila EE Parasitol Res; 2022 Dec; 121(12):3503-3512. PubMed ID: 36171407 [TBL] [Abstract][Full Text] [Related]
5. [In vitro susceptibility of Trichomonas vaginalis to metronidazole, ornidazole and proton pump inhibitors pantoprazole and esomeprazole]. Aksoy Gökmen A; Girginkardeşler N; Kilimcioğlu AA; Şirin MC; Özbilgin A Mikrobiyol Bul; 2016 Jan; 50(1):133-9. PubMed ID: 27058337 [TBL] [Abstract][Full Text] [Related]
6. Antiparasitic activity of furanyl N-acylhydrazone derivatives against Trichomonas vaginalis: in vitro and in silico analyses. Alves MSD; das Neves RN; Sena-Lopes Â; Domingues M; Casaril AM; Segatto NV; Nogueira TCM; de Souza MVN; Savegnago L; Seixas FK; Collares T; Borsuk S Parasit Vectors; 2020 Feb; 13(1):59. PubMed ID: 32046788 [TBL] [Abstract][Full Text] [Related]
7. Exploring novel pyrazole-nitroimidazole hybrids: Synthesis and antiprotozoal activity against the human pathogen trichomonas vaginalis. Silva RC; De Freitas A; Vicente B; Midlej V; Dos Santos MS Bioorg Med Chem; 2024 Mar; 102():117679. PubMed ID: 38461555 [TBL] [Abstract][Full Text] [Related]
8. Anti-Trichomonas vaginalis activity of ursolic acid derivative: a promising alternative. Bitencourt FG; de Brum Vieira P; Meirelles LC; Rigo GV; da Silva EF; Gnoatto SCB; Tasca T Parasitol Res; 2018 May; 117(5):1573-1580. PubMed ID: 29572567 [TBL] [Abstract][Full Text] [Related]
16. Chlorinated metronidazole as a promising alternative for treating trichomoniasis. Chacon MO; Fonseca THS; Oliveira SBV; Alacoque MA; Franco LL; Tagliati CA; Cassali GD; Campos-Mota GP; Alves RJ; Capettini LSA; Gomes MA Parasitol Res; 2018 May; 117(5):1333-1340. PubMed ID: 29502297 [TBL] [Abstract][Full Text] [Related]
17. Hydrogenosome metabolism is the key target for antiparasitic activity of resveratrol against Trichomonas vaginalis. Mallo N; Lamas J; Leiro JM Antimicrob Agents Chemother; 2013 Jun; 57(6):2476-84. PubMed ID: 23478970 [TBL] [Abstract][Full Text] [Related]
18. Synthesis, antiprotozoal activity, and chemoinformatic analysis of 2-(methylthio)-1H-benzimidazole-5-carboxamide derivatives: Identification of new selective giardicidal and trichomonicidal compounds. Flores-Carrillo P; Velázquez-López JM; Aguayo-Ortiz R; Hernández-Campos A; Trejo-Soto PJ; Yépez-Mulia L; Castillo R Eur J Med Chem; 2017 Sep; 137():211-220. PubMed ID: 28595066 [TBL] [Abstract][Full Text] [Related]
19. Genetic Indicators of Drug Resistance in the Highly Repetitive Genome of Trichomonas vaginalis. Bradic M; Warring SD; Tooley GE; Scheid P; Secor WE; Land KM; Huang PJ; Chen TW; Lee CC; Tang P; Sullivan SA; Carlton JM Genome Biol Evol; 2017 Jun; 9(6):1658-1672. PubMed ID: 28633446 [TBL] [Abstract][Full Text] [Related]
20. A systematic review of the literature on mechanisms of 5-nitroimidazole resistance in Graves KJ; Novak J; Secor WE; Kissinger PJ; Schwebke JR; Muzny CA Parasitology; 2020 Nov; 147(13):1383-1391. PubMed ID: 32729451 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]